Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma

Oncology Reports

Volumn 27, Issue 1, 2012, Pages 69-76

  Vizio, Barbara ^a   Mauri, Francesco A ^b   Prati, Adriana ^a   Trivedi, Pritesh ^b   Giacobino, Alice ^c   Novarino, Anna ^b   Satolli, Maria Antonietta ^c   Ciuffreda, Libero ^c   Camandona, Michele ^a   Gasparri, Guido ^a   Bellone, Graziella ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c Azienda Ospedaliera Universitaria San Giovanni Battista   (Italy)

Author keywords

ABCG2; Aldehyde dehydrogenase; Cancer stem cells; CD133; Jagged; Nestin; Notch; Pancreatic adenocarcinoma; Tissue microarray

Indexed keywords

ALDEHYDE DEHYDROGENASE; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CELL MARKER; JAGGED1; JAGGED2 PROTEIN; MEMBRANE PROTEIN; NESTIN; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER STEM CELL; CELL RENEWAL; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TISSUE MICROARRAY; TUMOR GROWTH; UPREGULATION;

ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; PANCREAS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855293870     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1461     Document Type: Article

References (55)

1. Sultana A, Smith CT, Cunningham D, Starling N, Neoptolemos JP and Ghaneh P: Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol 25: 2607-2615, 2007. (Pubitemid 47041235)
2. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001. (Pubitemid 33041634)
3. Bissell MJ and LaBarge MA: Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvi-ronment? Cancer Cell 7: 17-23, 2005. (Pubitemid 40126379)
4. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hema-topoietic cell. Nat Med 3: 730-737, 1997. (Pubitemid 27298715)
5. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003. (Pubitemid 36418143)
6. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004. (Pubitemid 39551674)
7. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immuno-deficient mice. Nature 445: 106-110, 2007. (Pubitemid 46067310)
8. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C and De MR: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007. (Pubitemid 46067311)
9. Collins AT and Maitland NJ: Prostate cancer stem cells. Eur J Cancer 42: 1213-1218, 2006. (Pubitemid 43795097)
10. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S and Rhim JS: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67: 3153-3161, 2007. (Pubitemid 46724852)
11. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di VA, Conticello C, Ruco L, Peschle C and De MR: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514, 2008. (Pubitemid 351267301)
12. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037, 2007.
13. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323, 2007. (Pubitemid 47355323)
14. Schofield R: The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4: 7-25, 1978.
15. Soltysova A, Altanerova V and Altaner C: Cancer stem cells. Neoplasma 52: 435-440, 2005. (Pubitemid 41809399)
16. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohisto-chemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987 (In German).
17. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003. (Pubitemid 37187480)
18. Donnenberg VS, Landreneau RJ and Donnenberg AD: Tumor-igenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. J Control Release 122: 385-391, 2007. (Pubitemid 47404670)
19. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, Gritti A, Piccinini A, Porro D, Santinami M, Invernici G, Parati E, Alessandri G and La Porta CA: Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43: 935-946, 2007. (Pubitemid 46366698)
20. Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D and Camussi G: Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166: 545-555, 2005. (Pubitemid 40189050)
21. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ and Guan XY: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132: 2542-2556, 2007. (Pubitemid 46890873)
22. Kania G, Corbeil D, Fuchs J, Tarasov KV, Blyszczuk P, Huttner WB, Boheler KR and Wobus AM: Somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cell-derived progenitors. Stem Cells 23: 791-804, 2005. (Pubitemid 40791794)
23. Hori Y, Fukumoto M and Kuroda Y: Enrichment of putative pancreatic progenitor cells from mice by sorting for prominin1 (CD133) and platelet-derived growth factor receptor beta. Stem Cells 26: 2912-2920, 2008.
24. Wang YH, Li F, Luo B, Wang XH, Sun HC, Liu S, Cui YQ and Xu XX: A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma 56: 371-378, 2009.
25. Lendahl U, Zimmerman LB and McKay RD: CNS stem cells express a new class of intermediate filament protein. Cell 60: 585-595, 1990.
26. Yang J, Cheng L, Yan Y, Bian W, Tomooka Y, Shiurba R and Jing N: Mouse nestin cDNA cloning and protein expression in the cytoskeleton of transfected cells. Biochim Biophys Acta 1520: 251-254, 2001.
27. Hunziker E and Stein M: Nestin-expressing cells in the pancreatic islets of Langerhans. Biochem Biophys Res Commun 271: 116-119, 2000. (Pubitemid 30444865)
28. Treutelaar MK, Skidmore JM, Dias-Leme CL, Hara M, Zhang L, Simeone D, Martin DM and Burant CF: Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes 52: 2503-2512, 2003. (Pubitemid 37210538)
29. Kawamoto M, Ishiwata T, Cho K, Uchida E, Korc M, Naito Z and Tajiri T: Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. Hum Pathol 40: 189-198, 2009.
30. Delacour A, Nepote V, Trumpp A and Herrera PL: Nestin expression in pancreatic exocrine cell lineages. Mech Dev 121: 3-14, 2004. (Pubitemid 38050174)
31. Esni F, Stoffers DA, Takeuchi T and Leach SD: Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas. Mech Dev 121: 15-25, 2004. (Pubitemid 38050175)
32. Ishiwata T, Kudo M, Onda M, Fujii T, Teduka K, Suzuki T, Korc M and Naito Z: Defined localization of nestin-expressing cells in L-arginine-induced acute pancreatitis. Pancreas 32: 360-368, 2006. (Pubitemid 43772191)
33. Kim SY, Lee SH, Kim BM, Kim EH, Min BH, Bendayan M and Park IS: Activation of nestin-positive duct stem (NPDS) cells in pancreas upon neogenic motivation and possible cytodifferentiation into insulin-secreting cells from NPDS cells. Dev Dyn 230: 1-11, 2004. (Pubitemid 38544068)
34. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284: 770-776, 1999. (Pubitemid 29291335)
35. Callahan R and Egan SE: Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 9: 145-163, 2004. (Pubitemid 39177500)
36. Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS, Ali S, Abbruzzese JL, Gallick GE and Sarkar FH: Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 69: 2400-2407, 2009.
37. Parsa I, Longnecker DS, Scarpelli DG, Pour P, Reddy JK and Lefkowitz M: Ductal metaplasia of human exocrine pancreas and its association with carcinoma. Cancer Res 45: 1285-1290, 1985. (Pubitemid 15111293)
38. Lee KM, Yasuda H, Hollingsworth MA and Ouellette MM: Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells. Lab Invest 85: 1003-1012, 2005. (Pubitemid 41486425)
39. Mumm JS and Kopan R: Notch signaling: from the outside in. Dev Biol 228: 151-165, 2000. (Pubitemid 32011983)
40. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A and Kopan R: A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518-522, 1999.
41. Struhl G and Greenwald I: Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398: 522-525, 1999.
42. Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM, Wolfe MS, Hruban RH, Ball DW, Schmid RM and Leach SD: Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3: 565-576, 2003. (Pubitemid 36808651)
43. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U and Edlund H: Notch signalling controls pancreatic cell differentiation. Nature 400: 877-881, 1999. (Pubitemid 29406724)
44. Radtke F and Raj K: The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3: 756-767, 2003. (Pubitemid 37328814)
45. Stylianou S, Clarke RB and Brennan K: Aberrant activation of notch signaling in human breast cancer. Cancer Res 66: 1517-1525, 2006. (Pubitemid 43259933)
46. Nickoloff BJ, Osborne BA and Miele L: Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 22: 6598-6608, 2003. (Pubitemid 37372340)
47. Buchler P, Gazdhar A, Schubert M, Giese N, Reber HA, Hines OJ, Giese T, Ceyhan GO, Muller M, Buchler MW and Friess H: The Notch signaling pathway is related to neuro-vascular progression of pancreatic cancer. Ann Surg 242: 791-800, 2005.
48. Glavinas H, Krajcsi P, Cserepes J and Sarkadi B: The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 1: 27-42, 2004.
49. Haimeur A, Conseil G, Deeley RG and Cole SP: The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5: 21-53, 2004. (Pubitemid 38294344)
50. Konig J, Hartel M, Nies AT, Martignoni ME, Guo J, Buchler MW, Friess H and Keppler D: Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer 115: 359-367, 2005. (Pubitemid 40663738)
51. Yoshida A, Rzhetsky A, Hsu LC and Chang C: Human aldehyde dehydrogenase gene family. Eur J Biochem 251: 549-557, 1998. (Pubitemid 28108946)
52. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-3389, 2009.
53. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS and Dontu G: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567, 2007. (Pubitemid 350056407)
54. Douville J, Beaulieu R and Balicki D: ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 18: 17-25, 2009.
55. Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, Goggins M, Iacobuzio-Donahue C, Berman DM, Laheru D, Jimeno A, Hidalgo M, Maitra A and Matsui W: Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst 102: 340-351, 2010.